TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.
Saved in:
| Title: | TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. |
|---|---|
| Authors: | Kvistborg P; The Netherlands Cancer Institute; Department of Immunology; Amsterdam, The Netherlands., Shu CJ, Heemskerk B, Fankhauser M, Thrue CA, Toebes M, van Rooij N, Linnemann C, van Buuren MM, Urbanus JH, Beltman JB, Thor Straten P, Li YF, Robbins PF, Besser MJ, Schachter J, Kenter GG, Dudley ME, Rosenberg SA, Haanen JB, Hadrup SR, Schumacher TN |
| Source: | Oncoimmunology [Oncoimmunology] 2012 Jul 01; Vol. 1 (4), pp. 409-418. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
